230 related articles for article (PubMed ID: 29483385)
1. Comparison of Clinical Effects between Percutaneous Transluminal Septal Myocardial Ablation and Modified Morrow Septal Myectomy on Patients with Hypertrophic Cardiomyopathy.
Guo HC; Li JH; Jiang TY; Ren CW; Dai J; Zhou YJ; Lai YQ
Chin Med J (Engl); 2018 Mar; 131(5):527-531. PubMed ID: 29483385
[TBL] [Abstract][Full Text] [Related]
2. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery.
Qin JX; Shiota T; Lever HM; Kapadia SR; Sitges M; Rubin DN; Bauer F; Greenberg NL; Agler DA; Drinko JK; Martin M; Tuzcu EM; Smedira NG; Lytle B; Thomas JD
J Am Coll Cardiol; 2001 Dec; 38(7):1994-2000. PubMed ID: 11738306
[TBL] [Abstract][Full Text] [Related]
3. Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy--a meta analysis.
Zeng Z; Wang F; Dou X; Zhang S; Pu J
Int J Cardiol; 2006 Sep; 112(1):80-4. PubMed ID: 16507323
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous transluminal septal myocardial ablation: past, present, and future.
Maekawa Y; Takamisawa I; Takano H; Takayama M
J Cardiol; 2022 Sep; 80(3):211-217. PubMed ID: 34924238
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets.
van der Lee C; ten Cate FJ; Geleijnse ML; Kofflard MJ; Pedone C; van Herwerden LA; Biagini E; Vletter WB; Serruys PW
Circulation; 2005 Jul; 112(4):482-8. PubMed ID: 16027255
[TBL] [Abstract][Full Text] [Related]
6. Reverse remodeling after percutaneous transluminal septal myocardial ablation in severe but asymptomatic LVOT obstruction (RASTA) study: Rationale and design of transcatheter septal reduction in asymptomatic patients with severe hypertrophic obstructive cardiomyopathy.
Arslan F; Akdim F; Ten Berg JM
Catheter Cardiovasc Interv; 2021 Feb; 97(3):488-492. PubMed ID: 32808736
[TBL] [Abstract][Full Text] [Related]
7. Real-world clinical outcomes of percutaneous transluminal septal myocardial ablation for patients with drug-refractory hypertrophic obstructive cardiomyopathy: results from a retrospective multicenter registry of non-high-volume centers.
Nakamura K; Toba T; Otake H; Kakizaki S; Fujimoto D; Takahashi Y; Fukuyama Y; Kawamori H; Tanaka H; Takaya T; Iwasaki M; Kozuki A; Kawai H; Hayashi T; Shite J; Hirata KI
Heart Vessels; 2022 Nov; 37(11):1937-1946. PubMed ID: 35641828
[TBL] [Abstract][Full Text] [Related]
8. Successful percutaneous transluminal septal myocardial ablation through a right superior septal artery for a patient with hypertrophic obstructive cardiomyopathy.
Kurita T; Tsuchikane E; Tanaka N; Suzuki T
Cardiovasc Interv Ther; 2015 Oct; 30(4):377-81. PubMed ID: 25502014
[TBL] [Abstract][Full Text] [Related]
9. Comparison of surgical results in patients with hypertrophic obstructive cardiomyopathy after classic or modified morrow septal myectomy.
Lai Y; Guo H; Li J; Dai J; Ren C; Wang Y
Medicine (Baltimore); 2017 Dec; 96(51):e9371. PubMed ID: 29390532
[TBL] [Abstract][Full Text] [Related]
10. Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
Veselka J; Honek T
Int J Cardiol; 2003 Mar; 88(1):27-32. PubMed ID: 12659981
[TBL] [Abstract][Full Text] [Related]
11. [Long-term outcome of patients with hypertrophic obstructive cardiomyopathy post percutaneous transluminal septal ablation].
Zheng SW; Shi HY; Dai JJ; Chen H; Wu WH; Qiu XB
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):294-301. PubMed ID: 32370480
[No Abstract] [Full Text] [Related]
12. Comparison of Valsalva manoeuvre and exercise in echocardiographic evaluation of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.
Jensen MK; Havndrup O; Pecini R; Dalsgaard M; Hassager C; Helqvist S; Kelbæk H; Jørgensen E; Køber L; Bundgaard H
Eur J Echocardiogr; 2010 Oct; 11(9):763-9. PubMed ID: 20472917
[TBL] [Abstract][Full Text] [Related]
13. Ameliorating the severity of sleep-disordered breathing concomitant with heart failure status after percutaneous transluminal septal myocardial ablation for drug-refractory hypertrophic obstructive cardiomyopathy.
Akita K; Maekawa Y; Kohno T; Tsuruta H; Murata M; Fukuda K
Heart Vessels; 2017 Nov; 32(11):1320-1326. PubMed ID: 28555387
[TBL] [Abstract][Full Text] [Related]
14. Is There a Role for Alcohol Septal Ablation in Young Patients with Medically Refractory Hypertrophic Obstructive Cardiomyopathy?
Sivakumar K; Jain G
Pediatr Cardiol; 2024 Mar; 45(3):648-659. PubMed ID: 36995405
[TBL] [Abstract][Full Text] [Related]
15. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy].
Qiao SB; Gao RL; You SJ; Yuan JS; Chen JL; Yang YJ
Zhonghua Nei Ke Za Zhi; 2006 Mar; 45(3):210-2. PubMed ID: 16624154
[TBL] [Abstract][Full Text] [Related]
16. Long term exercise capacity in patients with hypertrophic cardiomyopathy treated with percutaneous transluminal septal myocardial ablation.
Malek LA; Chojnowska L; Klopotowski M; Maczynska R; Demkow M; Witkowski A; Kusmierczyk B; Piotrowicz E; Konka M; Dabrowski M; Ruzyllo W
Eur J Heart Fail; 2008 Nov; 10(11):1123-6. PubMed ID: 18840395
[TBL] [Abstract][Full Text] [Related]
17. [Non-pharmacologic therapy of hypertrophic obstructive cardiomyopathy--results of therapy based on percutaneous transluminal septal myocardial ablation compared with results of dual-chamber cardiac pacing].
Krejcí J; Groch L; Meluzín J; Vykypel T; Halámek J; Vitovec J
Vnitr Lek; 2006 Apr; 52(4):313-20. PubMed ID: 16755987
[TBL] [Abstract][Full Text] [Related]
18. [Repeated percutaneous transluminal septal myocardial ablation leads to reduction of left ventricular outflow-tract pressure gradient in hypertrophic obstructive cardiomyopathy: a case report].
Takeda M; Mori T; Ohashi Y; Ichikawa S; Terashima M; Ejiri J; Awano K
J Cardiol; 2006 Jun; 47(6):313-21. PubMed ID: 16800375
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy; The Chinese experience in 119 patients from a single center.
Li ZQ; Cheng TO; Zhang WW; Qiao SB; Zhao LY; Jin YZ; Guan RM; Liu L
Int J Cardiol; 2004 Feb; 93(2-3):197-202. PubMed ID: 14975547
[TBL] [Abstract][Full Text] [Related]
20. Myectomy versus alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Afanasyev AV; Bogachev-Prokophiev AV; Kashtanov MG; Astapov DA; Zalesov AS; Budagaev SA; Sharifulin RM; Idov EM; Zheleznev SI
Interact Cardiovasc Thorac Surg; 2020 Aug; 31(2):158-165. PubMed ID: 32386304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
